Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood vessels engineered from human cells.

Melissa Poh1, Matthew Boyer, Amy Solan

  • 1Duke University Medical Center, Duke University, Durham, NC, USA.

Lancet (London, England)
|June 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time cardiac power output index predicts imminent need for extracorporeal membrane oxygenation after heart transplantation.

JHLT open·2026
Same author

Vasoplegia as a distinct hemodynamic phenotype after heart transplantation: Prevalence, determinants, and clinical consequences despite preserved allograft function.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Low intraoperative oxygen extraction during heart transplant reduces primary graft dysfunction risk in allografts with prolonged ischemic time.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Recipient Obesity and Heart Sizing: Gaining a Broader Understanding Within Heart Transplantation.

Annals of thoracic surgery short reports·2026
Same author

Engineering function in lung biology: integrating imaging, regenerative constructs, and functional biodesign.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Editorial Expression of Concern: Creation of human tumour cells with defined genetic elements.

Nature·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
See all related articles

Telomere extension via telomerase expression overcomes the limited lifespan of adult somatic cells in tissue engineering. This breakthrough enables the creation of engineered blood vessels from elderly patients, offering potential bypass grafts for vascular disease.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cell Biology

Background:

  • Tissue engineering faces challenges due to the limited replicative capacity of adult somatic cells.
  • Clinical applications for engineered tissues are hindered by cellular senescence.

Purpose of the Study:

  • To investigate telomerase expression as a method to extend cellular lifespan in human vascular tissue engineering.
  • To assess the feasibility of creating functional engineered tissues using cells from elderly donors.

Main Methods:

  • Vascular cells were isolated from elderly patients.
  • Telomerase expression was introduced to extend cellular lifespan.
  • Engineered autologous blood vessels were cultured.

Main Results:

Related Experiment Videos

  • Telomerase expression successfully extended the replicative capacity of vascular cells.
  • The culture of engineered autologous blood vessels was achieved.
  • The study demonstrated the potential for using aged cells in tissue engineering.

Conclusions:

  • Overcoming cellular senescence through telomerase expression is crucial for advancing human tissue engineering.
  • Engineered vascular grafts hold promise as bypass conduits for atherosclerotic disease patients.